HCM
BIIB icon

Horan Capital Management’s Biogen BIIB Stock Holding History

Horan Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-497
Closed -$175K – 60
2018
Q3 		$175K Sell
497
-13,349
-96% -$4.6M 0.03% 56
2018
Q2 		$4.02M Sell
13,846
-8,907
-39% -$2.5M 0.79% 30
2018
Q1 		$6.23M Sell
22,753
-413
-2% -$128K 1.35% 25
2017
Q4 		$7.38M Sell
23,166
-311
-1% -$99.8K 1.47% 28
2017
Q3 		$7.35M Buy
23,477
+3,009
+15% +$891K 1.53% 27
2017
Q2 		$5.55M Buy
20,468
+14,072
+220% +$3.72M 1.21% 29
2017
Q1 		$1.75M Buy
6,396
+13
+0.2% +$3.68K 0.4% 41
2016
Q4 		$1.81M Sell
6,383
-291
-4% -$86.3K 0.47% 39
2016
Q3 		$2.09M Buy
6,674
+2,379
+55% +$705K 0.55% 38
2016
Q2 		$1.04M Buy
+4,295
New +$1.13M 0.29% 47

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Horan Capital Management's BIIB Position: Q4 2018 in Review

Horan Capital Management sold out of Biogen (BIIB) in Q4 2018, closing a stake of 497 shares — an estimated $175K sold.

Horan Capital Management first reported a position in BIIB in Q2 2016 and held it in 10 quarters. The position peaked at $7.38M in Q4 2017. 1,141 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

  • Horan Capital Management reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
  • Horan Capital Management sold 497 Biogen shares in Q4 2018, an estimated $175K.
  • Horan Capital Management first reported a position in Biogen in Q2 2016 and held it in 10 quarters.
  • Horan Capital Management's Biogen position peaked at $7.38M in Q4 2017.
  • 1,141 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on Horan Capital Management's 13F filing for Q4 2018, filed 14 Jan 2019.